A latest report has been added to the wide database of Biologics Safety Testing Market by Infinium Global Research. This report studies the Biologics Safety Testing Market by instruments and services (instruments, kits, reagents, services), test type (endotoxin, adventitious agent detection and residual host contaminant detection tests), application (tissue-related and blood-related products testing) market status and outlook of global and major regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. Biologics Safety Testing Market provides opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and product offerings of the major companies in the Biologics Safety Testing Market. According to the report the Global Biologics Safety Testing Market is projected to grow at a CAGR between 12.0% and 12.5 % in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

Get a Sample Request

https://www.infiniumglobalresearch.com/reports/sample_request/708

 

Market Insights:

The report identified that global biologics safety testing is driven by factors such as number of drug launches are increased, technological advancements, increase in biotechnology and pharmaceutical industries driven by government support and regulations. While the restraining factors include high cost of biologics safety testing. Further, the report identifies the opportunities in the world market as emerging markets offer profitable growth opportunities, increasing pharmaceutical outsourcing.

 

Segments Covered

The report on global biologics safety testing market covers the segments based on instruments and services, test type, and application. The instruments and services of biologics safety testing include instruments, kits & reagents and services. The test type segment includes bioburden tests, endotoxin tests, adventitious agent detection tests, cell line authentication and characterization tests, residual host contaminant detection tests, adventitious agent detection tests and other test. On the basis of application the global biologics safety testing market is segmented as vaccine & therapeutics development, tissue and tissue-related products testing, blood and blood-related products testing, stem cell research and cellular and gene therapy.

 

Make an Enquiry

https://www.infiniumglobalresearch.com/reports/enquiry/708

 

Geographies covered

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography are provided over the period of 2017 – 2023.

 

Globally, North America market dominated the world biologics safety testing market followed by Europe and Asia-Pacific. Furthermore, Asia Pacific market is expected to grow at the highest CAGR over the forecast period 2017-2023. Due to the increasing emerging economies like china and India, growing population.

 

Companies Profiled:

The report provides profiles of the companies in the global biologics safety testing market such as, Toxikon Corporation, Charles River Laboratories International, Inc., Avance Biosciences Inc., Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd., Pace Analytical Services Inc., Eurofins Scientific Se, Wuxi Apptec, Sartorius AG, Cytovance Biologics, Inc.

 

Click the Below Full Report Link

https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_biologics_safety_testing_market

 

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global biologics safety testing market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of biologics safety testing market. Moreover, the study highlights current market trends and provides forecast from 2016 to 2023. We also have highlighted future trends in the biologics safety testing market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market.

This report will help manufacturers, suppliers and distributors of the biologics safety testing market to understand the present and future trends in this market and formulate their strategies accordingly.


Table of Contents:

1. Preface

1.1. Report description

1.2. Research methods

1.3. Research approaches

2. Executive Summary

3. Global Biologics Safety Testing Market Overview

3.1. Introduction

3.2. Market dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter’s five forces analysis

3.4. Competitive landscape in the Biologics Safety Testing Market

4. Global Biologics Safety Testing Market analysis, by Instruments and Services (USD million) 2017 – 2023

4.1. Instruments

4.2. Services

4.3. Kits & Reagents

5. Global Biologics Safety Testing Market analysis, by Test Type (USD million) 2017 – 2023

5.1. Bioburden Tests

5.2. Endotoxin Tests

5.3. Adventitious Agent Detection Tests

5.4. Cell Line Authentication and Characterization Tests

5.5. Sterility Tests

5.6. Residual Host Contaminant Detection Tests

5.7. Other Test Types

6. Global Biologics Safety Testing Market Analysis, by Application (USD million) 2017 – 2023

6.1. Vaccine & Therapeutics Development

6.2. Tissue and Tissue-Related Products Testing

6.3. Cellular and Gene Therapy

6.4. Blood and Blood-Related Products Testing

6.5. Stem Cell Research

7. Global Biologics Safety Testing Market Analysis, Regional Analysis (USD Million) 2017 – 2023

7.1. North America

7.1.1. North America Biologics Safety Testing Market by Instruments and Services (USD Million)

7.1.2. North America Biologics Safety Testing Market by Test Type (USD Million)

7.1.3. North America Biologics Safety Testing Market by Application (USD Million)

7.1.4. North America Biologics Safety Testing Market by country (USD Million)

7.2. Europe

7.2.1. Europe Biologics Safety Testing Market by Instruments and Services (USD Million)

7.2.2. Europe Biologics Safety Testing Market by Test Type (USD Million)

7.2.3. Europe Biologics Safety Testing Market by Application (USD Million)

7.2.4. Europe Biologics Safety Testing Market by country (USD Million)

7.3. Asia Pacific

7.3.1. Asia Pacific Biologics Safety Testing Market by Instruments and Services (USD Million)

7.3.2. Asia Pacific Biologics Safety Testing Market by Test Type (USD Million)

7.3.3. Asia Pacific Biologics Safety Testing Market by Application (USD Million)

7.3.4. Asia Pacific Biologics Safety Testing Market by country (USD Million)

7.4. Rest of the World (RoW)

7.4.1. RoW Biologics Safety Testing Market by Instruments and Services (USD Million)

7.4.2. RoW Biologics Safety Testing Market by Test Type (USD Million)

7.4.3. RoW Biologics Safety Testing Market by Application (USD Million)

7.4.4. RoW Biologics Safety Testing Market by Sub-region (USD Million)

8. Company profiles

8.1. Toxikon Corporation

8.2. Charles River Laboratories International, Inc.

8.3. Avance Biosciences Inc.

8.4. Thermo Fisher Scientific Inc.

8.5. Merck KGaA

8.6. Lonza Group Ltd.

8.7. Pace Analytical Services Inc.

8.8. Eurofins Scientific Se

8.9. Wuxi Apptec

8.10. Sartorius AG

8.11. Cytovance Biologics, Inc.

8.12. Source Bioscience